Biogen Inc. share price logo

Biogen Inc. Share Price

NASDAQ: BIIB

Large Cap

$144.89

+1.21

(+0.84%)

as on

Biogen Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $143.39
    $146.68
    downward going graph

    1.04%

    Downside

    1.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $110.04
    $204.18
    downward going graph

    24.06%

    Downside

    40.92%

    Upside

    downward going graph

Biogen Inc. share price movements today

Previous Close
$143.68
Open
$143.48
Volume
941.2K
Day's Low - High
$143.39 - $146.68
52 Week Low - High
$110.04 - $204.18

Biogen Inc. Historical Returns

1 Month Return
+ 6.59 %
3 Month Return
+ 14.49 %
1 Year Return
-26.68 %
3 Year Return
-30.44 %
5 Year Return
-47.22 %

Biogen Inc. Stock Fundamentals & Key Indicators

Check Biogen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$21.2B

EPS (TTM)

15.7406

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.08%

PE Ratio (TTM)

13.86

Industry PE ratio

16.65525641025641

P/B Ratio

13.8632

PEG Ratio

6.2424

EBITDA

3.2B

Revenue (TTM)

10.0B

Profit Margin

15.31%

Return On Equity TTM

9.13%

Biogen Inc. Stock Valuation

Track how Biogen Inc. P/E has moved over time to understand its valuation trends.

Biogen Inc. in the last 5 years

  • Overview

  • Trends

Lowest (7.62x)

September 30, 2020

Today (13.86x)

September 18, 2025

Industry (16.66x)

September 18, 2025

Highest (18.33x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 13.86x

Biogen Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biogen Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$21.2B-47.22%13.8615.31%
BUY$681.4B393.05%49.7125.91%
BUY$390.1B145.04%105.156.45%
BUY$247.9B67.63%14.5935.61%
BUY$426.8B18.78%18.9725.00%

Stock Returns calculator for Biogen Inc. Stock including INR - Dollar returns

The Biogen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biogen Inc. investment value today

Current value as on today

₹78,282

Returns

₹21,718

(-21.72%)

Returns from Biogen Inc. Stock

₹26,671 (-26.67%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Biogen Inc. Stock

Based on 42 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 42 analysts, 71.43% of analysts recommend a 'BUY' rating for Biogen Inc.. Average target price of $170.03

Biogen Inc. Share Price Target

Get share price movements and forecasts by analysts on Biogen Inc..

What analysts predicted

14.79%UPSIDE

Target Price

$170.03

Current Price

$144.89

Analyzed by

42 Analysts

Target

$170.03

Biogen Inc. target price $170.03, a slight upside of 14.79% compared to current price of $144.89. According to 42 analysts rating.

Biogen Inc. Stock's Interest Amongst Investors

Investment in Biogen Inc. Shares on INDmoney has grown by 175.86% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:175.86% versus previous 30 day period

Search interest for Biogen Inc. Stock has increased by 180% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:180% versus previous 30 day period

Biogen Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
2,463
2,456
2,530
2,386
2,290
2,464
2,465
2,454
2,431
2,645
Gross Profit
1,800
1,863
1,870
1,768
1,748
1,918
1,827
1,871
1,801
2,040
Operating Income
517
621
-141
425
577
701
496
450
625
851
EBITDA
613
750
47
601
681
918
693
535
554
1,010
Interest Expense
62
49
63
71
69
61
59
60
60
72
Depreciation
50
52
60
140
147
158
182
184
183
194
Income Before Tax
438
708
-141
291
464
698
451
291
311
744
Income Tax Expense
50
114
-72
42
71
115
62
24
70
109
Net Income
387
591
-68
249
393
583
388
266
240
634
Net Profit Margin
15.75%
24.09%
-2.69%
10.46%
17.18%
23.68%
15.76%
10.86%
9.89%
24.00%

Biogen Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
10,763
11,448
12,273
13,452
14,377
13,444
10,981
10,173
9,835
9,675
Gross Profit
9,523
9,970
10,643
11,636
12,422
11,639
8,872
7,895
7,302
7,365
Operating Income
4,891
5,150
5,344
5,888
7,042
4,550
2,840
2,901
2,097
2,218
EBITDA
5,615
5,875
6,096
6,750
7,777
5,730
3,923
4,357
2,377
2,829
Interest Expense
95
260
250
200
187
222
253
246
246
250
Depreciation
-
-
1,081
1,016
680
457
487
365
494
673
Income Before Tax
4,767
4,933
5,128
5,899
7,125
5,047
1,745
3,591
1,296
1,906
Income Tax Expense
1,161
1,237
2,458
1,425
1,158
992
52
632
135
273
Net Income
3,547
3,702
2,539
4,430
5,888
4,000
1,556
3,046
1,161
1,632
Net Profit Margin
32.95%
32.34%
20.69%
32.93%
40.96%
29.76%
14.17%
29.95%
11.81%
16.87%

Biogen Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
593
-68
248
393
583
388
266
240
634
Operating Cash Flow
487
592
12
553
625
935
760
259
160
Investing Cash Flow
-753
-1,742
-652
-66
466
-1,181
-18
-47
-57
Financing Cash Flow
-9
848
-646
-439
-245
-6
7
-23
-11
Change in Cash
-280
-329
-1,238
24
834
-209
675
223
160

Biogen Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
3,695
2,670
4,474
5,888
4,060
1,727
2,961
1,161
1,632
Operating Cash Flow
4,522
4,551
6,187
7,078
4,229
3,639
1,384
1,547
2,875
Investing Cash Flow
-2,484
-2,963
-2,046
470
-608
-563
1,576
-4,101
-799
Financing Cash Flow
-987
-2,380
-4,472
-5,860
-5,272
-2,086
-1,747
149
-683
Change in Cash
1,018
-752
-349
1,689
-1,582
930
1,157
-2,369
1,325

Global Institutional Holdings in Biogen Inc.

Funds
Holdings
Vanguard Group Inc
11.62%
PRIMECAP Management Company
10.87%
BlackRock Inc
10.37%
State Street Corp
5.05%
Wellington Management Company LLP
3.19%

Biogen Inc. News & Key Events

  • img

    Today's Timeline - 02 September

    Tue, 03:38 PM

    -

    Morgan Stanley analyst maintains Hold rating on Biogen, citing competitive pressures and pricing concerns for Leqembi.

    Tue, 05:47 PM

    -

    FDA approves injectable version of Alzheimer's drug Leqembi, developed by Biogen and Eisai.

Insights on Biogen Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.43B → 2.64B (in $), with an average increase of 8.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 240.5M → 634.8M (in $), with an average increase of 62.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Abbvie Inc has given 14.4% return, outperforming this stock by 41.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly And Company has given 53.3% return, outperforming this stock by 83.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, BIIB stock has moved down by -26.7%

About Biogen Inc.

through cutting-edge science and medicine, biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. founded in 1978, biogen is a pioneer in biotechnology and today the company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including alzheimer’s disease, parkinson’s disease and amyotrophic lateral sclerosis. biogen also manufactures and commercializes biosimilars of advanced biologics. with approximately 7000 people worldwide, we are truly a global organization, headquartered in cambridge, massachusetts, which is also home to our research operations. our international headquarters are based in zug, switzerland and we have world-class manufacturing facilities in north carolina and denmark. we offer therapies globally through direct affili
OrganisationBiogen Inc.
Headquarters225 Binney Street, Cambridge, MA, United States, 02142
IndustryHealth Technology
CEOMr. Christopher A. Viehbacher
E-voting on sharesClick here to vote

Key Management of Biogen Inc.

Name

Title

Mr. Christopher A. Viehbacher

President, CEO & Director

Ms. Susan H. Alexander Esq.

Executive VP & Chief Legal Officer

Mr. Sean Godbout

Chief Accounting Officer & Global Corporate Controller

Dr. Ginger Gregory Ph.D.

Executive VP & Chief Human Resources Officer

Ms. Nicole Murphy

Executive VP and Head of Pharmaceutical Operations & Technology

Dr. Priya Singhal M.D., M.P.H.

Executive VP & Head of Development

Ms. Robin C. Kramer

Executive VP & CFO

Mr. Tim Power M.B.A., Ph.D.

Head of Investor Relations

Mr. Adam Keeney Ph.D.

Executive VP & Head of Corporate Development

Ms. Alisha A. Alaimo

President & Head of North America

FAQs

What is Biogen Inc. share price today?

Biogen Inc. share price today is $144.89 as on at the close of the market. Biogen Inc. share today touched a day high of $146.68 and a low of $143.39.

What is the 52 week high and 52 week low for Biogen Inc. share?

Biogen Inc. share touched a 52 week high of $204.18 on and a 52 week low of $110.04 on . Biogen Inc. stock price today i.e. is closed at $144.89,which is 29.04% down from its 52 week high and 31.68% up from its 52 week low.

What is Biogen Inc.'s market capitalisation today?

Biogen Inc. market capitalisation is $0.02T as on .

How to invest in Biogen Inc. Stock (BIIB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biogen Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biogen Inc. Shares that will get you 0.0104 shares as per Biogen Inc. share price of $144.89 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Biogen Inc. Stock (BIIB) from India?

Indian investors can start investing in Biogen Inc. (BIIB) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Biogen Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Biogen Inc. share’s latest price of $144.89 as on September 18, 2025 at 1:29 am IST, you will get 0.0690 shares of Biogen Inc.. Learn more about fractional shares .

What are the returns that Biogen Inc. has given to Indian investors in the last 5 years?

Biogen Inc. stock has given -47.22% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?